Michael J. Fox has publicly expressed frustration over the Trump administration’s perceived indifference toward advancing Parkinson’s disease research, a cause he has championed for years. In a recent interview with Harrison Ford, Fox highlighted the gap between his foundation’s efforts and the limited federal government involvement in funding such research.
The Michael J. Fox Foundation, established in 2000, reportedly directs more funding toward Parkinson’s research than the federal government itself. Fox emphasized,
“Our foundation directs more money towards Parkinson’s research than the federal government,”
and added,
“It’s frustrating to know we’re putting everything we can into it, and it would be nice to have the government behind us, but it seems that they’re involved in other things that have less impact on people’s lives.”
When questioned about engaging directly with then-President Trump, Fox suggested Trump’s attention was elsewhere, commenting,
“He’s busy with Greenland. More pressing concerns, I guess.”
Fox’s Personal Battle and Advocacy for Parkinson’s Disease
Diagnosed with Parkinson’s disease at age 29 during the height of his acting career, Fox has since become one of the most vocal advocates for research and awareness surrounding this progressive neurodegenerative disorder. Despite keeping his diagnosis private for several years, he used his public platform to rally support and funding for scientific breakthroughs.
The disease impacts the central nervous system and currently has no cure. Other notable individuals affected include NFL star Brett Favre and singer Linda Ronstadt. Over more than two decades, the Michael J. Fox Foundation has raised over $2.5 billion to support innovative Parkinson’s research.
Fox’s dedication earned him the Presidential Medal of Freedom, awarded by then-President Joe Biden shortly before leaving office. The honor recognized both his accomplished acting career and his relentless commitment to finding better treatments for Parkinson’s disease.
Appeals to Government Leaders to Prioritize Parkinson’s Research
In the days before Trump’s second inauguration, Fox wrote an impassioned essay urging policymakers nationwide to intensify their efforts against Parkinson’s disease. He called on elected officials to
“do everything in their power to end Parkinson’s once and for all.”
Fox explained,
“Parkinson’s is a solvable problem, but only if we act decisively and urgently. We have the knowledge, and we’ve built the tools. We stand ready to partner with the government, this time with unprecedented potential to deliver enormous payoffs for American families.”
He also remarked,
“Elected officials pledge to make our lives better. This is a chance to make good on that promise.”
Ongoing Commitment Despite Frustrations with Progress
One year later, Fox expressed some disappointment with the government’s apparent inertia but maintained hope for future collaboration. He plans to meet with Health Secretary Robert F. Kennedy Jr. in Washington, D.C., aiming to discuss a more focused approach to brain research.
Fox said,
“I’m going to Washington next month and hopefully talk to Kennedy and find out what the government’s game plan is on addressing brain research in general and taking a more serious approach to some of these things that are soluble.”
He described Parkinson’s as “just a weird disease,” adding,
“We always say genetics loads a gun and environment pulls the trigger. We’re trying to figure out what’s biological and what’s chemical.”
Fox Returns to Acting with a Parkinson’s-Related Role on Apple TV+
This week, Fox returns to television in the third season of the Apple TV series Shrinking, where he portrays Gerry, a character navigating a Parkinson’s diagnosis. The show also stars Harrison Ford and Jason Segel, with Ford playing Dr. Paul Rhoades, a therapist living with the disease.
Although Fox retired from acting in 2020, he clarified that this role does not mark a career comeback. He told the Los Angeles Times,
“The depth of character, the quality of relationships, the language — it’s just a beautiful show. And I thought, just do that for its own sake.”
He emphasized,
“I don’t have an agenda. Don’t have to be coming back into acting or anything. It’ll be fun. And there’s Harrison Ford, which is insane.”
The Broader Context and Future Outlook
Michael J. Fox’s ongoing advocacy and foundation work remain critical drivers for Parkinson’s research, especially given the disease’s complex biological and environmental factors. Despite setbacks in government collaboration, his efforts underscore a wider urgency to accelerate scientific advances and improve the lives of those affected.
With his anticipated meeting with Robert F. Kennedy Jr., Fox hopes to influence future policies supporting brain health research. Meanwhile, his role on Shrinking aims to bring greater public awareness to the realities of Parkinson’s, blending personal experience with storytelling to deepen understanding of the disease.
